These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 3144527)

  • 1. Fleroxacin, a long acting fluoroquinolone with broad spectrum activity. International Congress of Chemotherapy. Istanbul, Turkey, 19-24 July 1987. Proceedings.
    J Antimicrob Chemother; 1988 Oct; 22 Suppl D():1-234. PubMed ID: 3144527
    [No Abstract]   [Full Text] [Related]  

  • 2. The cytotoxic effect of fleroxacin and ciprofloxacin on transitional cell carcinoma in vitro.
    Ebisuno S; Inagaki T; Kohjimoto Y; Ohkawa T
    Cancer; 1997 Dec; 80(12):2263-7. PubMed ID: 9404703
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro activity of E-4868, a new fluoroquinolone with a 7-azetidin ring, compared with ciprofloxacin, ofloxacin and fleroxacin.
    Mirelis B; Navarro F; Miró E; Coll R; Xicota MA; Prats G
    Drugs Exp Clin Res; 1995; 21(4):129-38. PubMed ID: 8529525
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-performance liquid chromatographic assay and erythrocyte partitioning of fleroxacin, a new fluoroquinolone antibiotic.
    Brunt E; Limberg J; Derendorf H
    J Pharm Biomed Anal; 1990; 8(1):67-71. PubMed ID: 2129330
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Renal tolerance of fleroxacin in healthy volunteers.
    Mondorf AW; Buch A; Steinbacher G; Rüdel C; Falkenberg FW
    J Antimicrob Chemother; 1988 Oct; 22 Suppl D():179-89. PubMed ID: 2904925
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics of Ro 23-6240 (AM 833), a new trifluorinated quinolone.
    Weidekamm E; Stöckel K; Dell D
    Chemioterapia; 1987 Jun; 6(2 Suppl):307-8. PubMed ID: 3151346
    [No Abstract]   [Full Text] [Related]  

  • 7. Single dose therapy with Ro 23-6240 in patients suffering from acute, non-complicated gonococcal infection.
    Eugster H; Eichmann A
    Chemioterapia; 1987 Jun; 6(2 Suppl):546-7. PubMed ID: 3151353
    [No Abstract]   [Full Text] [Related]  

  • 8. Fleroxacin (Ro 23-6240) in the treatment of gonorrhoea.
    Boerema JB; Moesker HL; Notowicz ; Van de Rhee HJ
    J Antimicrob Chemother; 1988 Jan; 21(1):140-1. PubMed ID: 3128518
    [No Abstract]   [Full Text] [Related]  

  • 9. Adverse reactions in a dose-ranging study with a new long-acting fluoroquinolone, fleroxacin.
    Bowie WR; Willetts V; Jewesson PJ
    Antimicrob Agents Chemother; 1989 Oct; 33(10):1778-82. PubMed ID: 2511802
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prediction of response to cancer therapy. Proceedings of a symposium held at the XVth International Chemotherapy Congress. Istanbul, Turkey, July 19-24, 1987. Proceedings.
    Prog Clin Biol Res; 1988; 276():1-309. PubMed ID: 3174673
    [No Abstract]   [Full Text] [Related]  

  • 11. Penetration of fleroxacin into maxillary sinus mucosa and palatine tonsil.
    Baba S; Mori Y; Maruo T
    J Antimicrob Chemother; 1988 Oct; 22 Suppl D():195-7. PubMed ID: 3144538
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolism of fleroxacin in man.
    Sörgel F; Seelmann R; Naber K; Metz R; Muth P
    J Antimicrob Chemother; 1988 Oct; 22 Suppl D():169-78. PubMed ID: 3144535
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A multicenter study on the comparative in vitro activity of fleroxacin and three other quinolones: an interim report from 27 centers.
    Beskid G; Prosser BL
    Am J Med; 1993 Mar; 94(3A):2S-8S. PubMed ID: 8383919
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An assessment of cerebral blood flow and metabolism after fleroxacin therapy.
    Gardner SF; Green JA; Bednarczyk EM; Nelson AD; Leisure G; Miraldi F
    J Clin Pharmacol; 1991 Feb; 31(2):151-7. PubMed ID: 1901321
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Once-daily fleroxacin versus twice-daily ciprofloxacin in the treatment of complicated urinary tract infections.
    Frankenschmidt A; Naber KG; Bischoff W; Kullmann K
    J Urol; 1997 Oct; 158(4):1494-9. PubMed ID: 9302150
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fleroxacin concentrations in myometrium, ovary and fallopian tube.
    Portmann R; Hansz C; Stiglmayer R; Weidekamm E
    J Antimicrob Chemother; 1989 Apr; 23(4):662-4. PubMed ID: 2501273
    [No Abstract]   [Full Text] [Related]  

  • 17. Developmental toxicity of fleroxacin and comparative pharmacokinetics of four fluoroquinolones in the cynomolgus macaque (Macaca fascicularis).
    Hummler H; Richter WF; Hendrickx AG
    Toxicol Appl Pharmacol; 1993 Sep; 122(1):34-45. PubMed ID: 8397453
    [TBL] [Abstract][Full Text] [Related]  

  • 18. "Sulbactam: worldwide clinical experience": a symposium. XV International Congress of Chemotherapy. Istanbul, Turkey, July 21, 1987. Proceedings.
    APMIS Suppl; 1989; 5():1-69. PubMed ID: 2736131
    [No Abstract]   [Full Text] [Related]  

  • 19. Endothelial cell compatibility of fluoroquinolone solutions for intravenous use.
    Vorbach H; Weigel G; Robibaro B; Schaumann R; Hlousek M; Beil WJ; Griesmacher A; Georgopoulos A; Graninger W
    Int J Clin Pharmacol Ther; 1997 Jun; 35(6):235-8. PubMed ID: 9208338
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Fluoroquinolones as etiology of tendinopathy].
    Gabutti L; Stoller R; Marti HP
    Ther Umsch; 1998 Sep; 55(9):558-61. PubMed ID: 9789471
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.